SCHEMBL4102391

SCHEMBL4102391

CCc1cc(-c2ccc(-c3cc(CCC(=O)O)[nH]n3)cc2)ccc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.60
MAPT P10636 5/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
ALPL P05186 3/20 0.41
CA9 Q16790 2/20 0.41
CA12 O43570 1/20 0.41
FFAR1 O14842 2/20 0.40
LTB4R Q15722 1/20 0.40
LTB4R2 Q9NPC1 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HSD17B1 P14061 1/20 0.40
PTGDR Q13258 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4092430 0.91 NR1H4 (0.61) NR1H4MAPTMEN1GAAKMT2A
SCHEMBL4097796 0.81 ALPL (0.64) MAPTMEN1GAAKMT2AALPL
SCHEMBL15622965 0.76 NR1H4 (0.72) NR1H4MAPTGAAFFAR1RAB9A
SCHEMBL4085995 0.73 SMN1; SMN2 (0.54) MAPTMEN1KMT2AFFAR1RAB9A
SCHEMBL9252117 0.72 NR1H4 (0.63) NR1H4ALPLCA12
SCHEMBL4092658 0.72 HSD17B1 (0.45) MAPTMEN1GAAKMT2AHSD17B1
SCHEMBL4566709 0.71 NR1H4 (0.37) NR1H4MEN1KMT2ALTB4RLTB4R2
SCHEMBL12325012 0.71 HSD17B1 (0.59) MAPTHSD17B1ALDH1A1LMNA
SCHEMBL4085703 0.70 HSD17B1 (0.39) MEN1KMT2AHSD17B1PTGDR2PDE4A
SCHEMBL7734727 0.69 FFAR1 (0.47) NR1H4MAPTFFAR1LTB4RPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186900-A1 COMPOUND STERIX LIMITED (GB) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186900-A1 COMPOUND HSD17B2, HSD17B11, CYP17A1 NR1H4 145/4885MAPT 929/4885MEN1 1122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.